Vivo Capital and Arrowhead Pharmaceuticals Launch Visirna Therapeutics in Greater China Gallery

Vivo Capital and Arrowhead Pharmaceuticals Launch Visirna Therapeutics in Greater China

GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn Gallery

GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn

Legend Biotech Announces FDA Approval of CARVYKTI Gallery

Legend Biotech Announces FDA Approval of CARVYKTI

Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering Gallery

Lepu Biotech (LEPU biopharma Co., Ltd. ) Announces Pricing of Public Offering

Avistone Pharmaceuticals Secures $200M Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital Gallery

Avistone Pharmaceuticals Secures $200M Strategic Investment from Vivo Capital, Bain Capital and Primavera Capital

Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market  Gallery

Ablaze Pharmaceuticals Launches with $75M Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market 

Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) Gallery

Aadi Bioscience Announces FDA Approval FYARRO™ for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa)

IO Biotech, Inc. Announces Pricing of Initial Public Offering Gallery

IO Biotech, Inc. Announces Pricing of Initial Public Offering

PatientPop and Kareo Merge to Create All-In-One Provider Platform Gallery

PatientPop and Kareo Merge to Create All-In-One Provider Platform

Minerva Surgical Announces Pricing of Initial Public Offering Gallery

Minerva Surgical Announces Pricing of Initial Public Offering

Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering Gallery

Ventyx Biosciences Announces Pricing of Upsized Initial Public Offering

HistoWiz Raises $32M Series A Financing Gallery

HistoWiz Raises $32M Series A Financing

Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency Gallery

Ascendis Pharma A/S Announces U.S. FDA Approval of SKYTROFA®, the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency

Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK® Gallery

Vivo Capital’s Portfolio Company, Kadmon Announces an FDA approval for REZUROCK®

Sera Prognostics Announces Pricing of Initial Public Offering Gallery

Sera Prognostics Announces Pricing of Initial Public Offering

Sinovac is Granted Emergency Use by the World Health Organization (WHO) Gallery

Sinovac is Granted Emergency Use by the World Health Organization (WHO)

Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment Gallery

Scientia Raises $50M to Develop Guidewires and Microcatheters for Stroke, Cancer Treatment

Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capital Gallery

Esco Lifesciences Closes a Record-Setting $200M Series A Round Led by Vivo Capital

Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financing Gallery

Rgenta Therapeutics Announces the Successful Completion of Extension of Seed Financing

Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreement Gallery

Aadi Bioscience and Aerpio Pharmaceuticals Enter into a Definitive Merger Agreement

Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capital Gallery

Aerobiotix Raises $25M Growth Equity Financing Led by Vivo Capital

dMed Globaland Clinipace Merge to Accelerate Customer Success Gallery

dMed Globaland Clinipace Merge to Accelerate Customer Success

Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering Gallery

Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering

Instil Bio Announces Pricing of Upsized Initial Public Offering Gallery

Instil Bio Announces Pricing of Upsized Initial Public Offering

Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work Gallery

Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work

Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock Gallery

Terns Pharmaceuticals, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

Surgical Specialties is Acquired by Corza Health Gallery

Surgical Specialties is Acquired by Corza Health

Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry. Gallery

Vivo Capital’s Portfolio Co-Founder, Professor Frances Arnold, is Awarded as the First American Woman to Win the Nobel Prize in Chemistry.

Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China Gallery

Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China

Gracell Biotechnologies Announces Pricing of Initial Public Offering Gallery

Gracell Biotechnologies Announces Pricing of Initial Public Offering

Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription Gallery

Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription

PatientPop Announces $50M in Series C Funding Gallery

PatientPop Announces $50M in Series C Funding

ALX Oncology Announces Pricing of Initial Public Offering Gallery

ALX Oncology Announces Pricing of Initial Public Offering

Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Gallery

Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital

Genetron Health Announces Pricing of Initial Public Offering Gallery

Genetron Health Announces Pricing of Initial Public Offering

IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Gallery

IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Gallery

Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19

Legend Biotech Corporation Announces Pricing of Public Offering Gallery

Legend Biotech Corporation Announces Pricing of Public Offering

RemeGen Completes USD $100 Million Plus in Funding Gallery

RemeGen Completes USD $100 Million Plus in Funding

Gilead to Acquire Forty Seven for $4.9 Billion Gallery

Gilead to Acquire Forty Seven for $4.9 Billion

Passage Bio Announces Pricing of Initial Public Offering Gallery

Passage Bio Announces Pricing of Initial Public Offering

Revolution Medicines Announces Pricing of Initial Public Offering Gallery

Revolution Medicines Announces Pricing of Initial Public Offering

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors Gallery

Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors

Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants Gallery

Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants

IGM Biosciences Announces Pricing of Initial Public Offering Gallery

IGM Biosciences Announces Pricing of Initial Public Offering

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART Gallery

AtriCure Enters Into Definitive Agreement to Acquire SentreHEART

MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital Gallery

MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis Gallery

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine Gallery

Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering Gallery

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

Tricida Announces Pricing of Initial Public Offering Gallery

Tricida Announces Pricing of Initial Public Offering